Launch Marcus multi-agent experiments with independent CLI agents in tmux panes. Use when the user says "build X with Marcus", "run a Marcus experiment", "spawn N agents with Marcus", "/marcus", or references the Marcus multi-agent framework. This skill handles experiment setup, config generation, and spawning independent agent CLI processes that coordinate via the Marcus MCP server. Each agent runs in its own tmux pane with full autonomy. NOT for ClawTeam — this is specifically for the Marcus MCP-based multi-agent system. NOTE: "Marcus" is also the name of the MCP server that agents use for coordination. The /marcus skill launches experiments that USE the Marcus MCP server — they are complementary, not competing. The MCP server must be running before invoking this skill. The Marcus MCP server is agent-agnostic; this skill supports both Anthropic's claude CLI and OpenAI's codex CLI as agent harnesses (selected via --harness).
中文简介正在准备中。当前显示原文说明。
painted-porch/marcus☆ 162026年10月20日 更新
Launch Marcus multi-agent experiments with independent CLI agents in tmux panes. Use when the user says "build X with Marcus", "run a Marcus experiment", "spawn N agents with Marcus", "/marcus", or references the Marcus multi-agent framework. This skill handles experiment setup, config generation, and spawning independent agent CLI processes that coordinate via the Marcus MCP server. Each agent runs in its own tmux pane with full autonomy. NOT for ClawTeam — this is specifically for the Marcus MCP-based multi-agent system. NOTE: "Marcus" is also the name of the MCP server that agents use for coordination. The /marcus skill launches experiments that USE the Marcus MCP server — they are complementary, not competing. The MCP server must be running before invoking this skill. The Marcus MCP server is agent-agnostic; this skill supports Anthropic's claude CLI, OpenAI's codex CLI, and Google's gemini CLI as agent harnesses (selected via --harness).
中文简介正在准备中。当前显示原文说明。
painted-porch/marcus☆ 162026年10月20日 更新
Estimates the minimum biological replicates (or cells/events) for a target power at a target FDR in genomics experiments using ssizeRNA, PROPER, powsimR for scRNA-seq, and pilot-data dispersion estimation from DESeq2/edgeR. Covers the biological-versus-technical replication distinction (technical replicates do not add degrees of freedom for biological inference), replicate-number-versus-sequencing-depth budgeting, scRNA-seq sample-versus-cell allocation under a pseudobulk model, and the critique that "n=3" is a publication convention rather than a power calculation. Use when budgeting a sequencing experiment, writing the sample-size justification in a grant, estimating replicates from pilot data, allocating a fixed budget between samples and depth, or planning scRNA-seq cohort size. For clinical-trial sample size see clinical-biostatistics/power-and-sample-size; for the power-given-n direction see experimental-design/power-analysis.
中文简介正在准备中。当前显示原文说明。
lilinji/GeneTind-Life-Skills☆ 152026年8月21日 更新
Designs genomics experiments so technical nuisance variation (batch, lane, plate, flow cell, operator, reagent lot, processing day) is balanced against the biological variable of interest and therefore estimable rather than confounded, using constrained sample-to-batch assignment (designit, OSAT), the confounder/mediator/collider distinction, and the principle that no post-hoc correction recovers a fully confounded design. Covers detecting hidden batches with surrogate variable analysis, a decision table for downstream correction (ComBat-seq, RUVSeq, SVA) whose execution is deferred to differential-expression/batch-correction, and reproducibility metadata. Use when assigning samples to sequencing batches/lanes/plates, avoiding batch-condition confounding, deciding whether a design is salvageable by correction, choosing a correction method, or estimating the number of hidden batches. For the experimental unit, randomization, and blocking concepts see experimental-design/randomization-blocking.
中文简介正在准备中。当前显示原文说明。
lilinji/GeneTind-Life-Skills☆ 152026年8月21日 更新
Calculates statistical power for high-dimensional genomics experiments (bulk RNA-seq, scRNA-seq, ATAC-seq, ChIP-seq, methylation, proteomics) under negative-binomial count models using RNASeqPower, PROPER, and simulation via powsimR, distinguishing per-gene from marginal (transcriptome-wide) power, the role of mean expression and dispersion, and the sequencing-depth-versus-replicate tradeoff. Covers simulation as the honest default for overdispersed counts, FDR-aware average power versus single-test power, observed/post-hoc power as an anti-pattern, and the winner's-curse / Type-S / Type-M consequences of underpowering. Use when planning replicate number for a sequencing experiment, deciding whether to add depth or samples, choosing closed-form versus simulation power, estimating power from pilot dispersions, or justifying replication in a grant. For clinical-trial power see clinical-biostatistics/power-and-sample-size; for the inverse sample-size question see experimental-design/sample-size.
中文简介正在准备中。当前显示原文说明。
lilinji/GeneTind-Life-Skills☆ 152026年8月21日 更新
Design and evaluate paid-ad experiments with hypotheses, randomization units, sample-size and duration assumptions, guardrails, platform experiment tools, analysis, and decision rules. Use for A/B test, split test, experiment design, hypothesis, statistical significance, sample size, test duration, or experiment readout.
中文简介正在准备中。当前显示原文说明。
unempyd/revenueos☆ 72026年9月14日 更新
Audit PostHog experiments and feature flags for configuration issues, staleness, and best-practice violations. Read when the user asks to audit, health-check, or review experiments or feature flags, check flag hygiene, or verify experiment setup.
中文简介正在准备中。当前显示原文说明。
0xAidan/polymarket-bot-test☆ 42026年9月4日 更新
Analyze session replay patterns across experiment variants to understand user behavior differences. Use when the user wants to see how users interact with different experiment variants, identify usability issues, compare behavior patterns between control and test groups, or get qualitative insights to complement quantitative experiment results.
中文简介正在准备中。当前显示原文说明。
0xAidan/polymarket-bot-test☆ 42026年9月4日 更新
Estimates the minimum biological replicates (or cells/events) for a target power at a target FDR in genomics experiments using ssizeRNA, PROPER, powsimR for scRNA-seq, and pilot-data dispersion estimation from DESeq2/edgeR. Covers the biological-versus-technical replication distinction (technical replicates do not add degrees of freedom for biological inference), replicate-number-versus-sequencing-depth budgeting, scRNA-seq sample-versus-cell allocation under a pseudobulk model, and the critique that "n=3" is a publication convention rather than a power calculation. Use when budgeting a sequencing experiment, writing the sample-size justification in a grant, estimating replicates from pilot data, allocating a fixed budget between samples and depth, or planning scRNA-seq cohort size. For clinical-trial sample size see clinical-biostatistics/power-and-sample-size; for the power-given-n direction see experimental-design/power-analysis.
中文简介正在准备中。当前显示原文说明。
huang-sh/DeepScience☆ 42026年7月15日 更新
Calculates statistical power for high-dimensional genomics experiments (bulk RNA-seq, scRNA-seq, ATAC-seq, ChIP-seq, methylation, proteomics) under negative-binomial count models using RNASeqPower, PROPER, and simulation via powsimR, distinguishing per-gene from marginal (transcriptome-wide) power, the role of mean expression and dispersion, and the sequencing-depth-versus-replicate tradeoff. Covers simulation as the honest default for overdispersed counts, FDR-aware average power versus single-test power, observed/post-hoc power as an anti-pattern, and the winner's-curse / Type-S / Type-M consequences of underpowering. Use when planning replicate number for a sequencing experiment, deciding whether to add depth or samples, choosing closed-form versus simulation power, estimating power from pilot dispersions, or justifying replication in a grant. For clinical-trial power see clinical-biostatistics/power-and-sample-size; for the inverse sample-size question see experimental-design/sample-size.
中文简介正在准备中。当前显示原文说明。
huang-sh/DeepScience☆ 42026年7月15日 更新
Designs genomics experiments so technical nuisance variation (batch, lane, plate, flow cell, operator, reagent lot, processing day) is balanced against the biological variable of interest and therefore estimable rather than confounded, using constrained sample-to-batch assignment (designit, OSAT), the confounder/mediator/collider distinction, and the principle that no post-hoc correction recovers a fully confounded design. Covers detecting hidden batches with surrogate variable analysis, a decision table for downstream correction (ComBat-seq, RUVSeq, SVA) whose execution is deferred to differential-expression/batch-correction, and reproducibility metadata. Use when assigning samples to sequencing batches/lanes/plates, avoiding batch-condition confounding, deciding whether a design is salvageable by correction, choosing a correction method, or estimating the number of hidden batches. For the experimental unit, randomization, and blocking concepts see experimental-design/randomization-blocking.
中文简介正在准备中。当前显示原文说明。
huang-sh/DeepScience☆ 42026年7月15日 更新
Designs genomics experiments so technical nuisance variation (batch, lane, plate, flow cell, operator, reagent lot, processing day) is balanced against the biological variable of interest and therefore estimable rather than confounded, using constrained sample-to-batch assignment (designit, OSAT), the confounder/mediator/collider distinction, and the principle that no post-hoc correction recovers a fully confounded design. Covers detecting hidden batches with surrogate variable analysis, a decision table for downstream correction (ComBat-seq, RUVSeq, SVA) whose execution is deferred to differential-expression/batch-correction, and reproducibility metadata. Use when assigning samples to sequencing batches/lanes/plates, avoiding batch-condition confounding, deciding whether a design is salvageable by correction, choosing a correction method, or estimating the number of hidden batches. For the experimental unit, randomization, and blocking concepts see experimental-design/randomization-blocking.
中文简介正在准备中。当前显示原文说明。
peacezha/TRACE☆ 32026年10月20日 更新
Estimates the minimum biological replicates (or cells/events) for a target power at a target FDR in genomics experiments using ssizeRNA, PROPER, powsimR for scRNA-seq, and pilot-data dispersion estimation from DESeq2/edgeR. Covers the biological-versus-technical replication distinction (technical replicates do not add degrees of freedom for biological inference), replicate-number-versus-sequencing-depth budgeting, scRNA-seq sample-versus-cell allocation under a pseudobulk model, and the critique that "n=3" is a publication convention rather than a power calculation. Use when budgeting a sequencing experiment, writing the sample-size justification in a grant, estimating replicates from pilot data, allocating a fixed budget between samples and depth, or planning scRNA-seq cohort size. For clinical-trial sample size see clinical-biostatistics/power-and-sample-size; for the power-given-n direction see experimental-design/power-analysis.
中文简介正在准备中。当前显示原文说明。
peacezha/TRACE☆ 32026年10月20日 更新
Calculates statistical power for high-dimensional genomics experiments (bulk RNA-seq, scRNA-seq, ATAC-seq, ChIP-seq, methylation, proteomics) under negative-binomial count models using RNASeqPower, PROPER, and simulation via powsimR, distinguishing per-gene from marginal (transcriptome-wide) power, the role of mean expression and dispersion, and the sequencing-depth-versus-replicate tradeoff. Covers simulation as the honest default for overdispersed counts, FDR-aware average power versus single-test power, observed/post-hoc power as an anti-pattern, and the winner's-curse / Type-S / Type-M consequences of underpowering. Use when planning replicate number for a sequencing experiment, deciding whether to add depth or samples, choosing closed-form versus simulation power, estimating power from pilot dispersions, or justifying replication in a grant. For clinical-trial power see clinical-biostatistics/power-and-sample-size; for the inverse sample-size question see experimental-design/sample-size.
中文简介正在准备中。当前显示原文说明。
peacezha/TRACE☆ 32026年10月20日 更新
Translate an approved experiment spec into a launch runbook — platform binding (PostHog primary), feature flag setup, assignment unit, exposure event definition, instrumentation QA, dashboard wiring, ramp plan, monitoring, and rollback procedure. Platform-agnostic core with one strong PostHog adapter shipped; GrowthBook, Statsig, LaunchDarkly, Optimizely, and Eppo documented as a single mapping table the user adapts. Load when a spec is approved and ready to launch, or when the user says "set up the experiment", "wire this up in PostHog", "implement the test", "create the runbook", "launch checklist for this test", or when the experimentation orchestrator routes here.
中文简介正在准备中。当前显示原文说明。
dvy1987/agent-loom☆ 32026年8月8日 更新
Analyse experiment results, run validity checks (SRM, exposure parity, data integrity, novelty/primacy), interpret causally, make a ship/iterate/kill decision against the pre-declared rule, and append to cumulative learnings. Forces honest readouts — strips significance claims from underpowered or peek-violating tests; never lets directional results masquerade as causal wins. Load when results exist, or when the user says "read out this experiment", "analyse the test", "did the test win", "interpret the results", "what did we learn", "ship or kill", or when the experimentation orchestrator routes here.
中文简介正在准备中。当前显示原文说明。
dvy1987/agent-loom☆ 32026年8月8日 更新
Calculates statistical power for high-dimensional genomics experiments (bulk RNA-seq, scRNA-seq, ATAC-seq, ChIP-seq, methylation, proteomics) under negative-binomial count models using RNASeqPower, PROPER, and simulation via powsimR, distinguishing per-gene from marginal (transcriptome-wide) power, the role of mean expression and dispersion, and the sequencing-depth-versus-replicate tradeoff. Covers simulation as the honest default for overdispersed counts, FDR-aware average power versus single-test power, observed/post-hoc power as an anti-pattern, and the winner's-curse / Type-S / Type-M consequences of underpowering. Use when planning replicate number for a sequencing experiment, deciding whether to add depth or samples, choosing closed-form versus simulation power, estimating power from pilot dispersions, or justifying replication in a grant. For clinical-trial power see clinical-biostatistics/power-and-sample-size; for the inverse sample-size question see experimental-design/sample-size.
中文简介正在准备中。当前显示原文说明。
peacezha/HPClaw☆ 32026年10月11日 更新
Estimates the minimum biological replicates (or cells/events) for a target power at a target FDR in genomics experiments using ssizeRNA, PROPER, powsimR for scRNA-seq, and pilot-data dispersion estimation from DESeq2/edgeR. Covers the biological-versus-technical replication distinction (technical replicates do not add degrees of freedom for biological inference), replicate-number-versus-sequencing-depth budgeting, scRNA-seq sample-versus-cell allocation under a pseudobulk model, and the critique that "n=3" is a publication convention rather than a power calculation. Use when budgeting a sequencing experiment, writing the sample-size justification in a grant, estimating replicates from pilot data, allocating a fixed budget between samples and depth, or planning scRNA-seq cohort size. For clinical-trial sample size see clinical-biostatistics/power-and-sample-size; for the power-given-n direction see experimental-design/power-analysis.
中文简介正在准备中。当前显示原文说明。
peacezha/HPClaw☆ 32026年10月11日 更新
Designs genomics experiments so technical nuisance variation (batch, lane, plate, flow cell, operator, reagent lot, processing day) is balanced against the biological variable of interest and therefore estimable rather than confounded, using constrained sample-to-batch assignment (designit, OSAT), the confounder/mediator/collider distinction, and the principle that no post-hoc correction recovers a fully confounded design. Covers detecting hidden batches with surrogate variable analysis, a decision table for downstream correction (ComBat-seq, RUVSeq, SVA) whose execution is deferred to differential-expression/batch-correction, and reproducibility metadata. Use when assigning samples to sequencing batches/lanes/plates, avoiding batch-condition confounding, deciding whether a design is salvageable by correction, choosing a correction method, or estimating the number of hidden batches. For the experimental unit, randomization, and blocking concepts see experimental-design/randomization-blocking.
中文简介正在准备中。当前显示原文说明。
peacezha/HPClaw☆ 32026年10月11日 更新
Chaos Engineering discipline — proactive experimentation on distributed systems to build confidence in their resilience. Covers Netflix-inspired chaos principles, experiment design, blast radius control, LitmusChaos and Chaos Mesh usage, game day planning, and production safety. USE WHEN: validating system resilience before production incidents, designing chaos experiments, planning game days, implementing CI/CD chaos pipeline, or building confidence in fault tolerance. Triggers on "chaos engineering", "chaos experiment", "game day", "resilience test", "fault injection", "Litmus", "Chaos Mesh", "break things on purpose".
中文简介正在准备中。当前显示原文说明。
aAAaqwq/openclaw-team☆ 22026年6月18日 更新
Autonomous iterative experimentation loop for any programming task. Guides the user through defining goals, measurable metrics, and scope constraints, then runs an autonomous loop of code changes, testing, measuring, and keeping/discarding results. Inspired by Karpathy's autoresearch. USE FOR: autonomous improvement, iterative optimization, experiment loop, auto research, performance tuning, automated experimentation, hill climbing, try things automatically, optimize code, run experiments, autonomous coding loop. DO NOT USE FOR: one-shot tasks, simple bug fixes, code review, or tasks without a measurable metric.
中文简介正在准备中。当前显示原文说明。
jcasnellie69/homelab-config☆ 22026年10月16日 更新
协助撰写机器学习与AI研究论文,涵盖文献检索、实验设计、运行进度检查、结果分析、写作和投稿准备,并核验引用、处理审稿后的修改。
- 根据已有代码和结果撰写论文
- 规划支撑研究主张的实验
- 检查相关研究和引用
NousResearch/hermes-agent☆ 25.6万2026年10月20日 更新
在正式开发前,用一次性原型验证想法是否可行。协助整理疑问、调查方案、运行实验、比较方法,并记录结论、依据与限制,为下一步验证提供参考。
- 验证想法是否可行
- 通过原型比较不同库
- 开发前检验高风险假设
NousResearch/hermes-agent☆ 25.6万2026年10月20日 更新
将访谈、客服工单、问卷和使用记录整理为用于产品或设计决策的HTML页面,集中展示证据、主题、可信程度、改进方案比较及下一步实验。
- 综合分析访谈与客服工单
- 比较初始设置的改进方案
- 向相关人员分享证据与不确定性
nexu-io/open-design☆ 10.3万2026年10月21日 更新